Improvement in Baroreflex Sensitivity in OSAS

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2005 by Nagoya University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Nagoya University
ClinicalTrials.gov Identifier:
NCT00284037
First received: January 27, 2006
Last updated: NA
Last verified: May 2005
History: No changes posted

January 27, 2006
January 27, 2006
Not Provided
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Improvement in Baroreflex Sensitivity in OSAS
Not Provided

Individuals with obstructive sleep apnea syndrome (OSAS) are at high risk for cardiovascular morbidity and mortality. The effect of long-term nocturnal therapy with continuous positive airway pressure (CPAP) on daytime baroreflex sensitivity (BRS), a predictor of cardiac death, was investigated in OSAS patients.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Obstructive Sleep Apnea Syndrome
Device: continuous positive airway pressure therapy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • obstructive sleep apnea syndrome

Exclusion Criteria:

  • diabetes mellitus, chronic obstructive lung disease, coronary or valvular heart disease, congestive heart failure, renal failure, or endocrine dysfunction. Moreover, none of them were taking b-blockers, vasodilators, or inotropic agents at the time of enrollment in the study.
Both
20 Years to 70 Years
Not Provided
Contact: Akiko Noda, PhD +81-52-719-1537 a-noda@met.nagoya-u.ac.jp
Japan
 
NCT00284037
NU-06-A-0003
Not Provided
Not Provided
Nagoya University
Not Provided
Study Chair: Mitsuhiro Yokota, MD.PhD Department of Cardiovascular Genome Science, Nagoya University School of Medicine, Nagoya, Aichi, Japan
Nagoya University
May 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP